Recently Featured

Emerging Trends in Pharma Collaboration Highlighted by New Insights

April 11, 2026
Recent discussions among industry leaders emphasize the growing importance of collaboration in the pharmaceutical sector. As companies face increasing regulatory pressures and the need for rapid innovation, the ability to work together effectively has become a critical success factor. This shift is not merely a trend; it reflects a fundamental change in how pharmaceutical firms…

German CDMO Adragos Acquires Major French Sterile Injectables Plant from Sanofi

April 10, 2026
Adragos Pharma, a German contract development and manufacturing organization (CDMO), has acquired one of Europe’s largest sterile injectables production facilities from Sanofi for an undisclosed price. This strategic move underscores the growing trend of consolidation within the pharmaceutical manufacturing sector, particularly in the sterile injectables space, which has seen increased demand due to the ongoing…

Glenmark Goes Direct with New US Ryaltris Marketing Plan as It Drops Partner Model

April 10, 2026
Six years after entering a U.S. marketing partnership with Hikma Pharma for its seasonal allergy spray Ryaltris, India’s Glenmark Pharmaceuticals has decided to pursue a direct marketing strategy. This shift marks a significant change in Glenmark’s approach to the U.S. market, allowing the company to retain full control over its marketing efforts and potentially increase…

Bayer Adjusts Marketing Claims Following US Advertising Body Recommendation

April 10, 2026
Bayer has been directed to modify its marketing claims regarding the One A Day Men’s Pre-Conception Health Complete Multivitamin, specifically its purported benefits for enhancing male fertility. This recommendation follows a challenge from a competing firm, which raised concerns about the validity of Bayer’s promotional assertions. The intervention by the US advertising body underscores the…

Ongoing Cases